February 2021 - BioMedWire (BMW)

FridayFeb 26, 2021 1:50 pm

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Releases Record-Breaking Gross Revenue for January 2021

Company reports record gross revenues of C$1,089,502 last month “It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” states CEO Record revenue comes during one of slowest e-commerce periods of year, highlighting impact the company has in the plant-based marketplace PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) saw record gross revenues last month (https://ibn.fm/qro4v). The company released its monthly numbers, noting that gross revenues for January 2021 totaled a record-breaking C$1,089,502; cost of goods sold for the month reached C$751,356. “It is truly encouraging to achieve yet…

FridayFeb 26, 2021 1:37 pm

Predictive Oncology Inc. (NASDAQ: POAI) Receives ‘Buy’ Rating from Litchfield Hills Research in First Analyst Coverage Report

Calling POAI undervalued, Litchfield initiates coverage of Predictive Oncology with Buy rating, $3 price target The drug industry is changing as tools and technology to tailor drugs emerge, regulatory bodies focus on patients’ experiences, perspectives, needs Litchfield report notes several POAI strengths under “Investment Thesis” section A growing number of companies and health providers alike are paying attention to what the FDA is calling patient-focused drug development (“PFDD”), a systematic approach to help ensure that patients’ experiences, perspectives, needs and priorities are captured and meaningfully incorporated into drug development and evaluation. In that growing market, Predictive Oncology (NASDAQ: POAI), a…

FridayFeb 26, 2021 12:15 pm

Research on Sensitive Blood Test for Cancer Wins 2021 Top-10 Award

The Clinical Research Forum recently awarded cancer biologists from Weill Cornell Medicine its Top-10 Clinical Research Achievement Award for their 2020 study that described a sensitive blood test for detecting a cancer relapse or the disease’s progression. The findings of the study were reported in “Nature Medicine.” The group of researchers was led by associate professor of medicine, Dr. Dan Landau, who is also a member of the Sandra and Edward Meyer Cancer Center. The study’s first author was Dr. Asaf Zviran, a postdoctoral researcher in Landau’s laboratory. The model developed in their study utilizes DNA whole-genome sequencing of a…

FridayFeb 26, 2021 12:13 pm

Better Cancer Outcomes Possible with Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology

Imagin Medical Inc.’s patented i/Blue System revolutionizes the way surgeons are able to visualize the bladder and identify cancers during surgery The breakthrough technology of Imagin Medical’s i/Blue Imaging System rectifies the limitations of both white and blue light cystoscopies Bladder cystoscopies first target - multiple other endoscopic procedures planned Science and technology have continued to make striking advancements in cancer therapeutics and treatment protocols, improving upon on past successes and creating better outcomes for cancer patients. A prime example is an exciting new development in visualizing cancer during minimally invasive surgeries. Surgical imaging company Imagin Medical (CSE: IME) (OTCQB:…

ThursdayFeb 25, 2021 2:45 pm

Study Discovers That Protein Imbalance May Cause Cataracts

Cataracts are a common eye disease, and while researchers have yet to fully understand how the disease works, plenty of research has been done on this ailment. Recently, a group of researchers at the Technical University of Munich (“TUM”) found that the composition of the protein solution was a factor in the disease. The researchers’ findings go against the field’s popular opinion. TUM’s chair of biotechnology Prof. Johannes Buchner explained that the cells in an eye lens are comprised of a protein solution that is highly concentrated and normally clear. However, he continued, a protein imbalance may cause the proteins to…

ThursdayFeb 25, 2021 12:55 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health

Studies confirm natural active ingredient, which is in MustGrow’s biopesticide, has a positive impact on soil health Soil micro-organisms play crucial role in soil fertility, plant health MustGrow's safe, effective natural biopesticide is plant based, derived from the mustard seed's natural defense mechanism MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has released study findings that confirm that the active ingredient in its mustard plant-based technology actually has a positive impact on soil health (https://ibn.fm/AeMYp). The studies have found that an application of the natural ingredient Allyl Isothiocyanate (“AITC”) returns organic plant material to the soil and contributes to the environmental…

WednesdayFeb 24, 2021 3:25 pm

Report Finds Vaccine Passports Feasible, But May Face Some Difficulties

A report released last week from a panel led by Prof. Chris Dye and Prof. Melinda Mills from the University of Oxford, states that while coronavirus vaccine passports are a feasible idea, there are a few challenges that need to be addressed before they could be developed. The report was published at the Royal Society. The report, which also gave a summary of these issues, stated that the primary concern was that any passport should disclose if its holder was protected from the coronavirus and would not be able to transmit the disease. Apart from this, passports would also be…

WednesdayFeb 24, 2021 3:18 pm

United Medical Equipment Business Solutions Network Inc. Providing Solutions to Combat the Spread of COVID-19

UME is trusted supplier of FDA-approved antibody, antigen test kits United moved quickly to address growing needs created by COVID-19 Company dedicated to providing guidance to aging population, their families and medical staff supporting them United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted supplier of FDA-approved antibody and antigen test kits, medical equipment and personal protective equipment (“PPE”). As the world attempts to control this pandemic, it is essential to quickly identify who is infected and…

WednesdayFeb 24, 2021 1:34 pm

PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Collaboration with Farm Cup Coffee Designed to Boost Brand, Reach Customers and Inspire Lifestyles

PlantX to display and sell its indoor plants at Farm Cup Coffee’s highly attractive West Hollywood location The careful partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowerment PlantX opens wide the potential of indoor plants, making it both easy and appealing to discover what the world of plants can provide As the digital face of the plant-based community, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is taking another step to solidify its position as a one-stop shop for everything plant-based. The Company recently announced that has entered into a new collaboration with Farm Cup…

WednesdayFeb 24, 2021 1:19 pm

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiaries Ink Significant Contract, Announce Sale of Media to Top Medical Centers

POAI subsidiary inks contract with significant pharmaceutical company TumorGenesis announces sale of media to research medical centers in New York City, Boston Potential market for 3D cancer cell culture media expected to reach $3.2 billion sales worldwide by 2027 Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its wholly owned subsidiaries, Soluble Biotech, recently inked another contract with a large pharmaceutical company (https://ibn.fm/OpaJb). POAI also announced that TumorGenesis, one of its wholly owned subsidiaries, has sold media to two top research medical centers (https://ibn.fm/uXorQ). Soluble Biotech’s contract will…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

Month: February 2021

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Releases Record-Breaking Gross Revenue for January 2021

Predictive Oncology Inc. (NASDAQ: POAI) Receives ‘Buy’ Rating from Litchfield Hills Research in First Analyst Coverage Report

Research on Sensitive Blood Test for Cancer Wins 2021 Top-10 Award

Better Cancer Outcomes Possible with Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology

Study Discovers That Protein Imbalance May Cause Cataracts

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health

Report Finds Vaccine Passports Feasible, But May Face Some Difficulties

United Medical Equipment Business Solutions Network Inc. Providing Solutions to Combat the Spread of COVID-19

PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Collaboration with Farm Cup Coffee Designed to Boost Brand, Reach Customers and Inspire Lifestyles

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiaries Ink Significant Contract, Announce Sale of Media to Top Medical Centers

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search